Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT: A case report

Medicine (Baltimore). 2017 Nov;96(46):e8471. doi: 10.1097/MD.0000000000008471.

Abstract

Rationale: F-18 Fluoro Deoxyglucose positron emission tomography and computed tomography (F-18 FDG PET/CT) is a useful modality in the evaluation of patients with malignancies. Increased incidence of lympho-proliferative disorders has been reported in individuals with long-standing end-stage renal disorders treated with renal replacement therapy.

Patient concerns: A 30-year-old male on peritoneal dialysis on account of end-stage renal disease. He had acute rejection of an earlier transplanted renal allograft. He was referred for an F-18 FDG PET/CT based on a clinical suspicion of lymphoma on account of bilateral inguinal lymphadenopathy associated with bilateral pedal swelling.

Diagnosis: Renal osteodystrophy was diagnosed based on diffusely intense F-18 FDG uptake in the axial skeleton, focal uptake in the costochondrial junctions and linear cortical uptake in the appendicular skeleton. No findings suggestive of lymphoma was seen.

Interventions: A diagnosis of renal osteodystrophy with no evidence of a lymphoma prevented futile biopsy of inguinal lymphadenopathy. Patient continued with peritoneal dialysis with no further intervention OUTCOMES:: Regular follow-up of patient to monitor calcium, phosphate and parathyroid hormone levels. Treatment will be indicated when laboratory results as well as clinical signs and symptoms are suggestive.

Lesson: Metabolic bone disorder such as is seen in renal osteodystrophy should be considered in the differential diagnoses in patients with diffusely increased bone uptake on F-18 FDG PET/CT scan.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chronic Kidney Disease-Mineral and Bone Disorder / diagnostic imaging*
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Positron Emission Tomography Computed Tomography

Substances

  • Fluorodeoxyglucose F18